Bosentan
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2900 publications
Activin A-Endothelin-1 Axis Governs Pulmonary Vascular Remodeling: Mechanistic Basis for Emerging Therapies in PAH.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 02, 2026
A KCa 2.2/2.3 Opener Reverses ET-1-Induced NLRP3 Activation in Hypertensive Mice Corpora Cavernosa.
Journal: Biomolecules
Published: February 18, 2026
Heterogeneity in the efficacy of bosentan for hypertensive nephropathy: a study on individualized benefit prediction models based on pathological subtyping and dynamic trajectories.
Journal: Annals of medicine
Published: February 06, 2026
L-carnosine as a biocompatible dipeptide carrier for oral delivery of amorphous bosentan: the binary systems.
Journal: International journal of pharmaceutics
Published: January 07, 2026
Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries.
Journal: Journal of clinical medicine
Published: December 27, 2025
Systemic Sclerosis-Recent Advances in Diagnosis and Management.
Journal: British journal of hospital medicine (London, England : 2005)
Published: December 24, 2025
Retinal Assessment and the Retina-Choroid Link in Precapillary Pulmonary Hypertension: A Single-Center Cross-Sectional Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: December 19, 2025
Silver nanoparticles-based green fluorescent probe for determination of Bosentan in pharmaceutical formulation and spiked plasma samples.
Journal: BMC chemistry
Published: November 19, 2025
Sensitive voltammetric detection of bosentan using gold nanoparticles-decorated pencil graphite electrode in pharmaceutical formulations and plasma samples.
Journal: Scientific reports
Published: November 12, 2025
Exploring the potential of liver microphysiological systems of varied configurations to model cholestatic chemical effects.
Journal: Archives of toxicology
Published: October 27, 2025
The Involvement of the Peptidergic Systems in Breast Cancer Development.
Journal: Cancers
Published: October 07, 2025
Endothelin-1 in the failing Fontan: pathobiology, precision therapeutics, and future trial design.
Journal: Frontiers in pediatrics
Published: October 03, 2025
Last Updated: 04/28/2026